Skip to main content

BioArray Solutions Gets FDA Clearance for Bead Array Immunoassay

NEW YORK, June 15 (GenomeWeb News) - BioArray Solutions has received clearance from the US Food and Drug Administration for a bead array-based multiplexed immunoassay, the Warren, NJ-based company said today.

 

The 510(k) clearance covers the company's IgG BeadChip test system, an immunoassay for the simultaneous detection of six antibodies to different extractable nuclear antigens. The test will be used with BioArray's Array Imaging Ssystem, AIS 400, which employs a chip format for detection.

 

BioArray Solutions is currently developing other assays for protein and DNA analysis to run on its platform.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.